NCT02514967 CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis Status TERMINATED Phase PHASE3
NCT02472795 Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1/PHASE2
NCT02465580 A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE2
NCT02456168 Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus Status COMPLETED Phase N/A
NCT02453880 Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness Status COMPLETED Phase NA
NCT02443506 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02411136 A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02408471 Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis Status TERMINATED Phase NA
NCT02391259 A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT02364908 Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus Status COMPLETED Phase NA
NCT02338999 Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) Status COMPLETED Phase PHASE1/PHASE2
NCT02331810 Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients Status WITHDRAWN Phase PHASE1